Physician profile
Henry Choi
NPI 1699734723
$5,625.75
in general payments reported to CMS, 2019-2025
19 companies · $643 in 2025
The $643 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $741 · 2021: $311 · 2022: $1,426 · 2023: $1,005 · 2024: $1,176 · 2025: $643.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,823.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $814.12 | 2020-2023 | Acthar |
| Genentech USA, INC. | $751.95 | 2019-2025 | Vabysmo |
| Alimera Sciences, INC. | $584.77 | 2019-2024 | Iluvien, Yutiq |
| Abbvie INC. | $515.16 | 2022-2025 | Ozurdex |
| Regeneron Healthcare Solutions, INC. | $372.34 | 2020-2025 | Eylea, Eylea Hd |
| Apellis Pharmaceuticals, INC. | $345.60 | 2022-2025 | Syfovre |
| Novartis Pharmaceuticals Corporation | $327.25 | 2019-2021 | |
| Notal Vision, INC. | $283.48 | 2022 | |
| Eyepoint US, INC. | $277.27 | 2021-2023 | |
| Ani Pharmaceuticals, INC. | $253.91 | 2022-2025 | Purified Cortrophin Gel, Iluvien |
| Astellas Pharma US INC | $251.87 | 2023-2025 | Izervay |
| Coherus Oncology, INC. | $236.54 | 2022-2023 | |
| Dutch Ophthalmic, USA | $184.60 | 2022-2023 | Eva, Combined Machine, Tissueblue |
| Sandoz INC. | $168.68 | 2024-2025 | Cimerli |
| Allergan, INC. | $118.72 | 2019-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $45.66 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $40.64 | 2021 | |
| Ivantis, INC | $37.59 | 2019 | |
| Ocular Therapeutix, INC. | $15.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Henry Choi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.